Oxidative changes in the rat brain by intraperitoneal injection of ferric nitrilotriacetate

Ichiro Nakatsuka, Shigeru Maeda, Tsugunobu Andoh, Yukiko Hayashi, Ryuichiro Mizuno, Hitoshi Higuchi, Takuya Miyawaki

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Iron is known to be involved in neuronal diseases such as neurodegenerative diseases, brain ischemia and epilepsy. However, it is unclear if a high level of peripheral iron induces these pathological conditions. Since ferric nitrilotriacetate (Fe-NTA), a low molecule iron chelate, causes kidney carcinoma and diabetes in animals due to its strong and unique oxidative stress, it is also considered to cause pathological conditions in the brain. Therefore, we studied brain changes after intraperitoneal (i.p.) injection of Fe-NTA. We investigated iron distribution in the brain and evaluated heme oxygenase (HO)-1 mRNA, IL-6 mRNA and 4-hydroxy-2-nonenal (4-HNE) quantitatively. In addition, changes in muscarinic acetylcholine receptor mRNAs were measured. It was found that iron was localized in the cortex and the hypothalamus, but not in other areas of the brain. HO-1 was induced in both the cortex and hypothalamus, and the levels of IL-6 and 4-HNE were raised in the hypothalamus, but not in the cortex. In the cortex, expression in M1 and M2 mAChRs were suppressed. In conclusion, iron reached the brain parenchyma after i.p. injection of Fe-NTA, and Fe-NTA caused oxidative reactions and suppression of mAChRs in the brain.

Original languageEnglish
Pages (from-to)109-114
Number of pages6
JournalRedox Report
Volume14
Issue number3
DOIs
Publication statusPublished - 2009

Fingerprint

Intraperitoneal Injections
Rats
Brain
Iron
Hypothalamus
Heme Oxygenase-1
Interleukin-4
Messenger RNA
Interleukin-6
Iron Chelating Agents
Neurodegenerative diseases
Muscarinic Receptors
Oxidative stress
Brain Ischemia
Neurodegenerative Diseases
Medical problems
ferric nitrilotriacetate
Epilepsy
Oxidative Stress
Animals

Keywords

  • Cortex
  • Ferric nitrilotriacetate
  • Heme oxygenase
  • Hyphothalamus
  • Iron
  • Muscarinic acetylcholine receptors
  • Neuronal disease

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Clinical Biochemistry
  • Biochemistry, medical
  • Physiology
  • Medicine(all)

Cite this

Oxidative changes in the rat brain by intraperitoneal injection of ferric nitrilotriacetate. / Nakatsuka, Ichiro; Maeda, Shigeru; Andoh, Tsugunobu; Hayashi, Yukiko; Mizuno, Ryuichiro; Higuchi, Hitoshi; Miyawaki, Takuya.

In: Redox Report, Vol. 14, No. 3, 2009, p. 109-114.

Research output: Contribution to journalArticle

Nakatsuka, Ichiro ; Maeda, Shigeru ; Andoh, Tsugunobu ; Hayashi, Yukiko ; Mizuno, Ryuichiro ; Higuchi, Hitoshi ; Miyawaki, Takuya. / Oxidative changes in the rat brain by intraperitoneal injection of ferric nitrilotriacetate. In: Redox Report. 2009 ; Vol. 14, No. 3. pp. 109-114.
@article{7d12f32d3d244c23b2a0c207453f69bf,
title = "Oxidative changes in the rat brain by intraperitoneal injection of ferric nitrilotriacetate",
abstract = "Iron is known to be involved in neuronal diseases such as neurodegenerative diseases, brain ischemia and epilepsy. However, it is unclear if a high level of peripheral iron induces these pathological conditions. Since ferric nitrilotriacetate (Fe-NTA), a low molecule iron chelate, causes kidney carcinoma and diabetes in animals due to its strong and unique oxidative stress, it is also considered to cause pathological conditions in the brain. Therefore, we studied brain changes after intraperitoneal (i.p.) injection of Fe-NTA. We investigated iron distribution in the brain and evaluated heme oxygenase (HO)-1 mRNA, IL-6 mRNA and 4-hydroxy-2-nonenal (4-HNE) quantitatively. In addition, changes in muscarinic acetylcholine receptor mRNAs were measured. It was found that iron was localized in the cortex and the hypothalamus, but not in other areas of the brain. HO-1 was induced in both the cortex and hypothalamus, and the levels of IL-6 and 4-HNE were raised in the hypothalamus, but not in the cortex. In the cortex, expression in M1 and M2 mAChRs were suppressed. In conclusion, iron reached the brain parenchyma after i.p. injection of Fe-NTA, and Fe-NTA caused oxidative reactions and suppression of mAChRs in the brain.",
keywords = "Cortex, Ferric nitrilotriacetate, Heme oxygenase, Hyphothalamus, Iron, Muscarinic acetylcholine receptors, Neuronal disease",
author = "Ichiro Nakatsuka and Shigeru Maeda and Tsugunobu Andoh and Yukiko Hayashi and Ryuichiro Mizuno and Hitoshi Higuchi and Takuya Miyawaki",
year = "2009",
doi = "10.1179/135100009X392575",
language = "English",
volume = "14",
pages = "109--114",
journal = "Redox Report",
issn = "1351-0002",
publisher = "Maney Publishing",
number = "3",

}

TY - JOUR

T1 - Oxidative changes in the rat brain by intraperitoneal injection of ferric nitrilotriacetate

AU - Nakatsuka, Ichiro

AU - Maeda, Shigeru

AU - Andoh, Tsugunobu

AU - Hayashi, Yukiko

AU - Mizuno, Ryuichiro

AU - Higuchi, Hitoshi

AU - Miyawaki, Takuya

PY - 2009

Y1 - 2009

N2 - Iron is known to be involved in neuronal diseases such as neurodegenerative diseases, brain ischemia and epilepsy. However, it is unclear if a high level of peripheral iron induces these pathological conditions. Since ferric nitrilotriacetate (Fe-NTA), a low molecule iron chelate, causes kidney carcinoma and diabetes in animals due to its strong and unique oxidative stress, it is also considered to cause pathological conditions in the brain. Therefore, we studied brain changes after intraperitoneal (i.p.) injection of Fe-NTA. We investigated iron distribution in the brain and evaluated heme oxygenase (HO)-1 mRNA, IL-6 mRNA and 4-hydroxy-2-nonenal (4-HNE) quantitatively. In addition, changes in muscarinic acetylcholine receptor mRNAs were measured. It was found that iron was localized in the cortex and the hypothalamus, but not in other areas of the brain. HO-1 was induced in both the cortex and hypothalamus, and the levels of IL-6 and 4-HNE were raised in the hypothalamus, but not in the cortex. In the cortex, expression in M1 and M2 mAChRs were suppressed. In conclusion, iron reached the brain parenchyma after i.p. injection of Fe-NTA, and Fe-NTA caused oxidative reactions and suppression of mAChRs in the brain.

AB - Iron is known to be involved in neuronal diseases such as neurodegenerative diseases, brain ischemia and epilepsy. However, it is unclear if a high level of peripheral iron induces these pathological conditions. Since ferric nitrilotriacetate (Fe-NTA), a low molecule iron chelate, causes kidney carcinoma and diabetes in animals due to its strong and unique oxidative stress, it is also considered to cause pathological conditions in the brain. Therefore, we studied brain changes after intraperitoneal (i.p.) injection of Fe-NTA. We investigated iron distribution in the brain and evaluated heme oxygenase (HO)-1 mRNA, IL-6 mRNA and 4-hydroxy-2-nonenal (4-HNE) quantitatively. In addition, changes in muscarinic acetylcholine receptor mRNAs were measured. It was found that iron was localized in the cortex and the hypothalamus, but not in other areas of the brain. HO-1 was induced in both the cortex and hypothalamus, and the levels of IL-6 and 4-HNE were raised in the hypothalamus, but not in the cortex. In the cortex, expression in M1 and M2 mAChRs were suppressed. In conclusion, iron reached the brain parenchyma after i.p. injection of Fe-NTA, and Fe-NTA caused oxidative reactions and suppression of mAChRs in the brain.

KW - Cortex

KW - Ferric nitrilotriacetate

KW - Heme oxygenase

KW - Hyphothalamus

KW - Iron

KW - Muscarinic acetylcholine receptors

KW - Neuronal disease

UR - http://www.scopus.com/inward/record.url?scp=68949125368&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68949125368&partnerID=8YFLogxK

U2 - 10.1179/135100009X392575

DO - 10.1179/135100009X392575

M3 - Article

C2 - 19490752

AN - SCOPUS:68949125368

VL - 14

SP - 109

EP - 114

JO - Redox Report

JF - Redox Report

SN - 1351-0002

IS - 3

ER -